What does CUSIP 868459108 represent in this 13F holders report?

CUSIP 868459108 is the security identifier for SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock in Q2 2015?

163 institutional investors reported SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock for Q2 2015. Use the holders table for investor-level position and value details.

SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN)

CUSIP: 868459108

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class: Equity / Common Stock
Shares outstanding: 57,572,193
Total 13F shares: 42,547,309
Share change: +1,979,050
Total reported value: $722,438,662
Put/Call ratio: 84%
Price per share: $16.98
Number of holders: 163
Value change: +$78,289,744
Number of buys: 125
Number of sells: 51

Quarterly Holders Quick Answers

What is CUSIP 868459108?
CUSIP 868459108 identifies SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2015
Previous quarter: Q1 2015

Recent filing periods for CUSIP 868459108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
NEA Management Company, LLC	13F	Company	18%	10,650,000	$128,759,000	—	31 Mar 2015	13F
Consonance Capital Management LP	13F	Company	6.2%	3,566,923	$43,124,000	—	31 Mar 2015	13F
Michael R. Murphy	13F	Individual	4.6%	2,644,571	$31,973,000	—	31 Mar 2015	13F
Abingworth LLP	13F	Company	4%	2,303,462	$27,826,000	—	31 Mar 2015	13F
AMERIPRISE FINANCIAL INC	13F	Company	2.5%	1,427,997	$17,264,000	—	31 Mar 2015	13F
BlackRock Fund Advisors	13F	Company	2.4%	1,356,816	$16,404,000	—	31 Mar 2015	13F
NORTHPOINTE CAPITAL LLC	13F	Company	2.1%	1,208,258	$14,608,000	—	31 Mar 2015	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	1.8%	1,061,450	$12,833,000	—	31 Mar 2015	13F
ARDSLEY ADVISORY PARTNERS LP	13F	Company	1.7%	981,300	$11,864,000	—	31 Mar 2015	13F
VANGUARD GROUP INC	13F	Company	1.5%	885,629	$10,708,000	—	31 Mar 2015	13F
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC	13F	Company	1.3%	722,991	$8,741,000	—	31 Mar 2015	13F
Bruce & Co., Inc.	13F	Company	1.2%	694,581	$8,334,000	—	31 Mar 2015	13F
ASHFORD CAPITAL MANAGEMENT INC	13F	Company	1.2%	679,987	$8,221,000	—	31 Mar 2015	13F
KENNEDY CAPITAL MANAGEMENT LLC	13F	Company	1.2%	669,954	$8,100,000	—	31 Mar 2015	13F
KOPP INVESTMENT ADVISORS LLC	13F	Company	1.1%	613,590	$7,418,000	—	31 Mar 2015	13F
ORBIMED ADVISORS LLC	13F	Company	1%	580,000	$7,012,000	—	31 Mar 2015	13F
AlphaOne Investment Services, LLC	13F	Company	0.97%	558,961	$6,758,000	—	31 Mar 2015	13F
Opaleye Management Inc.	13F	Company	0.93%	535,000	$6,468,000	—	31 Mar 2015	13F
Iguana Healthcare Management, LLC	13F	Company	0.87%	500,000	$6,045,000	—	31 Mar 2015	13F
WHITEBOX ADVISORS LLC	13F	Company	0.79%	454,796	$5,498,000	—	31 Mar 2015	13F
Rhenman & Partners Asset Management AB	13F	Company	0.78%	450,800	$5,450,000	—	31 Mar 2015	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.74%	423,938	$5,125,000	—	31 Mar 2015	13F
C WorldWide Group Holding A/S	13F	Company	0.66%	380,000	$4,594,000	—	31 Mar 2015	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	0.65%	375,432	$4,539,000	—	31 Mar 2015	13F
STATE STREET CORP	13F	Company	0.63%	362,515	$4,383,000	—	31 Mar 2015	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.63%	361,314	$4,370,000	—	31 Mar 2015	13F
NORTHERN TRUST CORP	13F	Company	0.54%	313,023	$3,784,000	—	31 Mar 2015	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	0.5%	286,600	$3,465,000	—	31 Mar 2015	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.41%	233,484	$2,823,000	—	31 Mar 2015	13F
Allianz Asset Management GmbH	13F	Company	0.39%	225,862	$2,731,000	—	31 Mar 2015	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.38%	216,110	$2,613,000	—	31 Mar 2015	13F
CITADEL ADVISORS LLC	13F	Company	0.33%	190,404	$2,302,000	—	31 Mar 2015	13F
MENTA CAPITAL LLC	13F	Company	0.29%	168,597	$2,038,000	—	31 Mar 2015	13F
Spark Investment Management LLC	13F	Company	0.29%	166,300	$2,008,000	—	31 Mar 2015	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	0.28%	160,511	$1,941,000	—	31 Mar 2015	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.27%	154,205	$1,864,000	—	31 Mar 2015	13F
Ranger Investment Management, L.P.	13F	Company	0.26%	151,500	$1,832,000	—	31 Mar 2015	13F
FRANKLIN STREET ADVISORS INC /NC	13F	Company	0.25%	146,325	$1,769,000	—	31 Mar 2015	13F
TFS CAPITAL LLC	13F	Company	0.25%	143,529	$1,735,000	—	31 Mar 2015	13F
ZAZOVE ASSOCIATES LLC	13F	Company	0.24%	138,429	$1,674,000	—	31 Mar 2015	13F
Granite Investment Partners, LLC	13F	Company	0.23%	134,396	$1,625,000	—	31 Mar 2015	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.23%	133,471	$1,614,000	—	31 Mar 2015	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.23%	133,270	$1,611,000	—	31 Mar 2015	13F
Bank of New York Mellon Corp	13F	Company	0.22%	129,501	$1,565,000	—	31 Mar 2015	13F
REINHART PARTNERS, LLC.	13F	Company	0.21%	120,981	$1,463,000	—	31 Mar 2015	13F
Polar Capital LLP	13F	Company	0.19%	111,673	$1,350,000	—	31 Mar 2015	13F
CADENCE CAPITAL MANAGEMENT LLC	13F	Company	0.19%	111,020	$1,342,000	—	31 Mar 2015	13F
STIFEL FINANCIAL CORP	13F	Company	0.19%	109,332	$1,322,000	—	31 Mar 2015	13F
SOROS FUND MANAGEMENT LLC	13F	Company	0.19%	107,308	$1,297,000	—	31 Mar 2015	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.18%	104,208	$1,260,000	—	31 Mar 2015	13F

Institutional Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN) as of Q2 2015

As of 30 Jun 2015, SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN) was held by 163 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 42,547,309 shares. The largest 10 holders included NEA Management Company, LLC, BlackRock Fund Advisors, Murphy Michael R, Invesco Ltd., Ranger Investment Management, L.P., Apex Capital Management, VANGUARD GROUP INC, Ameriprise Financial Inc, PRICE T ROWE ASSOCIATES INC /MD/, and KOPP INVESTMENT ADVISORS LLC. This page lists 163 institutional shareholders reporting positions in this security for the Q2 2015 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2015 vs Q1 2015 Across Filers

Q1 2015 holders

116

Q2 2015 holders

163

Holder diff

Investor	Q1 2015 Shares	Q2 2015 Shares	Share Diff	Share Chg %	Q1 2015 Value $	Q2 2015 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.